Analgesics
Antiandrogens
Antihistamines
Budesonide
Colchicine
Conv. Plasma
Curcumin
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Monoclonals
Mpro inhibitors
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Quercetin
RdRp inhibitors
TMPRSS2 inh.
Thermotherapy
Vitamins
More

Other
Feedback
Home
 
next
study
previous
study
c19early.org COVID-19 treatment researchVitamin DVitamin D (more..)
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta
Ivermectin Meta
Thermotherapy Meta
Melatonin Meta
Metformin Meta

 

Exploring the association between vitamin D status and Corona Virus-19 infection in a cohort of adults aged 50 years and older

Wagner et al., Clinical Nutrition Open Science, doi:10.1016/j.nutos.2025.05.007, NCT04482673, May 2025
https://c19early.org/wagner3.html
Case 74% Improvement Relative Risk Vitamin D for COVID-19  Wagner et al.  Sufficiency Are vitamin D levels associated with COVID-19 outcomes? Prospective study of 131 patients in the USA (Jul 2020 - Dec 2021) Fewer cases with higher vitamin D levels (p=0.011) c19early.org Wagner et al., Clinical Nutrition Open.., May 2025 Favorsvitamin D Favorscontrol 0 0.5 1 1.5 2+
Vitamin D for COVID-19
8th treatment shown to reduce risk in October 2020, now with p < 0.00000000001 from 125 studies, recognized in 18 countries.
No treatment is 100% effective. Protocols combine treatments.
5,700+ studies for 169 treatments. c19early.org
Prospective study of 131 adults aged 50+ years showing lower vitamin D status was significantly associated with higher risk of COVID-19 infection and hospitalization. Adjusted results based on deficiency are only provided for cases (other adjusted results only use continuous values for vitamin D levels).
This is the 219th COVID-19 sufficiency study for vitamin D, which collectively show higher levels reduce risk with p<0.0000000001 (1 in 221,958,417,113 vigintillion).
Standard of Care (SOC) for COVID-19 in the study country, the USA, is very poor with very low average efficacy for approved treatments1. Only expensive, high-profit treatments were approved. Low-cost treatments were excluded, reducing the probability of treatment—especially early—due to access and cost barriers, and eliminating complementary and synergistic benefits seen with many low-cost treatments.
risk of case, 74.1% lower, RR 0.26, p = 0.01, high D levels 22 of 106 (20.8%), low D levels 22 of 25 (88.0%), NNT 1.5, inverted to make RR<1 favor high D levels, odds ratio converted to relative risk.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Wagner et al., 31 May 2025, prospective, USA, peer-reviewed, mean age 64.3, 12 authors, study period July 2020 - December 2021, trial NCT04482673 (history). Contact: wagnercl@musc.edu.
Exploring the association between vitamin D status and Corona Virus-19 infection in a cohort of adults aged 50 years and older
MD Carol L Wagner, PhD John E Baatz, Myla Ebeling, PhD Danforth A Newton, MS Judith R Shary, PhD Mathew Gregoski, PhD Mark T Wagner, PhD David Zava, Carole Baggerly, BS Sonya Ketchens, PhD Jeffrey Korte, PhD Bruce W Hollis
Clinical Nutrition Open Science, doi:10.1016/j.nutos.2025.05.007
Objective: Evaluate the association between vitamin D (vitD) status and Corona Virus-19 (COVID-19) infection in adults aged 50 years and older. Design: Adults ≥50 undergoing COVID-19 testing from July 2020 to December 2021, without prior vaccination, consented to blood analysis. SARS-CoV-2 PCR confirmed current COVID-19 infection. VitD status was assessed via 25(OH)D concentration (LCMS/MS, ZRT Labs, Portland, OR). Sociodemographic data were collected at enrollment. Statistical analyses (SAS 9.4) examined associations between sociodemographics, COVID-19, and vitD status. Multivariate logistic regression analyzed factors linked to COVID-19 or vitD status. Results: Of 131 participants, 46.6% were 65 years old, 71.0% married, 19.9% Black American, 36.6% male, 38.9% Medicaid/Medicare/self-pay, and 42.8% BMI30. VitD status and Black American (p=0.0001) significantly associated with COVID-19 infection (p=0.0001). Black American (p=0.0003), males (p=0.003), and BMI (p=0.007) were inversely associated with 25(OH)D concentration. In a multiple logistic regression model predicting COVID-19 infection, only vitamin D status remained significant after controlling for certain sociodemographic and clinical factors (p<0.0001, OR 0.92, 95% CI 0.89-0.95). Of the 44 COVID-positive participants, 35 (79.6%) were hospitalized and 19 (43.2%) were admitted to the Intensive Care Unit (ICU). Hospitalization due to COVID-19 was associated with age 65 years old (p=0.02; OR 12.0, 95% CI 1.34-106.79), male (p=0.02, OR 10.7, 95% CI 1.20-94.73), and 25(OH)D <40 ng/mL (p=0.0006, OR 42.5, 95% CI 3.90-461.01). In multivariate analysis, J o u r n a l P r e -p r o o f the association between vitamin D status and the risk of COVID-related hospitalization remained significant and inversely associated (p=0.03, OR 0.88, 95% CI 0.78-0.99). In unadjusted analysis, COVID pneumonia was associated with male sex (p=0.049; OR 4.6, 95% CI 1.06-20.16 ) and 25(OH)D <40 ng/mL (p=0.006, OR 18.8, 95% CI 1.9-184.10). Participants with COVID infection and 25(OH)D <20 ng/mL were 2.1 times more likely to be admitted to ICU/death (p=0.03). In unadjusted analysis, ICU admission and/or death were linked to age 65 years (p=0.0002, OR 16.9, 95% CI 3.63-78.56), Medicaid/Medicare/self-pay insurance status (p=0.004, OR 0.1, 0.04-0.56), and 25(OH)D <20 (p=0.03, OR 3.9, 1.09-13.66) and <40 ng/mL (p=0.03); however, only age ≥65 remained significant in multivariate analysis (p=0.04, OR 6.7, CI 1.05-43.0). Conclusions: Lower 25(OH)D concentration was a significant predictor and/or contributor to COVID-19 infection, suggesting the importance of maintaining adequate vitamin D status in reducing infection risk and mitigating severe outcomes.
Presentations
References
Bergman, Lindh, Bjorkhem-Bergman, Lindh, Vitamin D and Respiratory Tract Infections: A Systematic Review and Meta-Analysis of Randomized Controlled Trials, PloS one, doi:10.1371/journal.pone.0065835
Bergman, Norlin, Hansen, Vitamin D3 supplementation in patients with frequent respiratory tract infections: a randomised and double-blind intervention study, BMJ open, doi:10.1136/bmjopen-2012-001663
Bryson, Nash, Norval, Does vitamin D protect against respiratory viral infections?, Epidemiol Infect, doi:10.1017/S0950268814000193
Charoenngam, Holick, Immunologic Effects of Vitamin D on Human Health and Disease, Nutrients, doi:10.3390/nu12072097
Foong, Bosco, Jones, The effects of in utero vitamin D deficiency on airway smooth muscle mass and lung function, Am J Respir Cell Mol Biol, doi:10.1165/rcmb.2014-0356OC
Garg, Kim, Whitaker, Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 -COVID-NET, 14 States, March 1-30, 2020, MMWR Morb Mortal Wkly Rep, doi:10.15585/mmwr.mm6915e3
Garland, Comstock, Garland, Helsing, Shaw et al., Serum 25(OH)D and colon cancer: Eight-year prospective study, Lancet
Garland, Garland, Gorham, Young, Geographic variation in breast cancer mortality in the United States: A hypothesis involving exposure to solar radiation, Prev Med
Giovannucci, Liu, Hollis, Rimm, 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study, Archives of internal medicine, doi:10.1001/archinte.168.11.1174
Grant, The roles of vitamin D, temperature, and viral infections in seasonal risk of acquiring asthma, Am J Respir Crit Care Med, doi:10.1164/ajrccm.179.11.1072a
Grant, Vitamin, Status May Help Explain Racial Disparities in Pancreatic Cancer Incidence and Mortality in the United States. Clinical gastroenterology and hepatology : J o u r n a l P r e -p r o o f the official clinical practice journal of the American Gastroenterological Association, doi:10.1016/j.cgh.2019.12.033
Green, Cod liver oil and tuberculosis, BMJ, doi:10.1136/bmj.d7505
Hamilton, Mcneil, Hollis, Profound Vitamin D Deficiency in a Diverse Group of Women during Pregnancy Living in a Sun-Rich Environment at Latitude 32 degrees N, International journal of endocrinology, doi:10.1155/2010/917428
Hamming, Timens, Bulthuis, Lely, Navis et al., Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis, J Pathol, doi:10.1002/path.1570
Hansdottir, Monick, Vitamin D effects on lung immunity and respiratory diseases, Vitam Horm, doi:10.1016/B978-0-12-386960-9.00009-5
Hawrylowicz, Santos, Vitamin D: can the sun stop the atopic epidemic?, Curr Opin Allergy Clin Immunol, doi:10.1097/ACI.0000000000000613
Holick, Binkley, Bischoff-Ferrari, Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline, The Journal of clinical endocrinology and metabolism, doi:10.1210/jc.2011-0385
Hollis, Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D, The Journal of nutrition
Hollis, Johnson, Hulsey, Ebeling, Wagner, Vitamin D supplementation during pregnancy: Double-blind, randomized clinical trial of safety and effectiveness, Journal of Bone and Mineral Research, doi:10.1002/jbmr.463
Hollis, Marshall, Savage, Garrett-Mayer, Kindy et al., Vitamin D(3) supplementation, low-risk prostate cancer, and health disparities, The Journal of steroid biochemistry and molecular biology, doi:10.1016/j.jsbmb.2012.11.012
Hollis, Wagner, Drezner, Binkley, Circulating vitamin D3 and 25hydroxyvitamin D in humans: An important tool to define adequate nutritional vitamin D status, The Journal of steroid biochemistry and molecular biology, doi:10.1016/j.jsbmb.2006.12.066
Hollis, Wagner, Substantial Vitamin D Supplementation Is Required during the Prenatal Period to Improve Birth Outcomes, Nutrients, doi:10.3390/nu14040899
J O U R N A L P R E, None
Johnson, Wagner, Hulsey, Mcneil, Ebeling et al., Vitamin D Deficiency and Insufficiency is Common during Pregnancy, American journal of perinatology, doi:10.1016/j.ajog.2011.03.022
Keum, Lee, Greenwood, Manson, Giovannucci, Vitamin D supplementation and total cancer incidence and mortality: a meta-analysis of randomized controlled trials, Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, doi:10.1093/annonc/mdz059
Li, Hannah, Durbin, Multivariate Analysis of Factors Affecting COVID-19 Case and Death Rate in U.S. Counties: The Significant Effects of Black Race and Temperature, MedRxiv, doi:10.1101/2020.04.17.20069708
Maclaughlin, Holick, Aging decreases the capacity of the skin to produce vitamin D 3, The Journal of clinical investigation
Martineau, Jolliffe, Hooper, Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data, BMJ, doi:10.1136/bmj.i6583
Mcfee, COVID-19 Laboratory Testing/CDC Guidelines, Dis Mon, doi:10.1016/j.disamonth.2020.101067
Mcnally, Leis, Matheson, Karuananyake, Sankaran et al., Vitamin D deficiency in young children with severe acute lower respiratory infection, Pediatr Pulmonol
Meng, Li, Liu, The role of vitamin D in the prevention and treatment of SARS-CoV-2 infection: A meta-analysis of randomized controlled trials, Clin Nutr, doi:10.1016/j.clnu.2023.09.008
Mirzakhani, Litonjua, Mcelrath, Early pregnancy vitamin D status and risk of preeclampsia, The Journal of clinical investigation, doi:10.1172/JCI89031
Olliver, Spelmink, Hiew, Meyer-Hoffert, Henriques-Normark et al., Immunomodulatory Effects of Vitamin D on Innate and Adaptive Immune Responses to Streptococcus pneumoniae, The Journal of infectious diseases, doi:10.1093/infdis/jit355
Urashima, Segawa, Okazaki, Kurihara, Wada et al., Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren, The American journal of clinical nutrition, doi:10.3945/ajcn.2009.29094
Vignera, Cannarella, Condorelli, Torre, Aversa et al., Sex-Specific SARS-CoV-2 Mortality: Among Hormone-Modulated ACE2 Expression, Risk of Venous Thromboembolism and Hypovitaminosis D, International Journal of Molecular Sciences, doi:10.3390/ijms21082948
Wang, Wang, Jiang, Prevalence of vitamin D deficiency and associated risk of all-cause and cause-specific mortality among middle-aged and older adults in the United States, Front Nutr, doi:10.3389/fnut.2023.1163737
Young, Underdahl, Carpenter, Vitamin D intake and susceptibility of mice to experimental swine influenza virus infection, Proc Soc Exp Biol Med
Zhang, Cheng, He, Li, Ma et al., Effect of various doses of vitamin D supplementation on pregnant women with gestational diabetes mellitus: A randomized controlled trial, Exp Ther Med, doi:10.3892/etm.2016.3515
Zhang, Tu, Manson, Racial/Ethnic Differences in 25-Hydroxy Vitamin D and Parathyroid Hormone Levels and Cardiovascular Disease Risk Among Postmenopausal Women, J Am Heart Assoc, doi:10.1161/JAHA.118.011021
Zittermann, Schleithoff, Koerfer, Vitamin D insufficiency in congestive heart failure: why and what to do about it?, Heart failure reviews
Zou, Chen, Zou, Han, Hao et al., Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection, Front Med, doi:10.1007/s11684-020-0754-0
DOI record: { "DOI": "10.1016/j.nutos.2025.05.007", "ISSN": [ "2667-2685" ], "URL": "http://dx.doi.org/10.1016/j.nutos.2025.05.007", "alternative-id": [ "S2667268525000567" ], "assertion": [ { "label": "This article is maintained by", "name": "publisher", "value": "Elsevier" }, { "label": "Article Title", "name": "articletitle", "value": "Exploring the association between vitamin D status and Corona Virus-19 infection in a cohort of adults aged 50 years and older" }, { "label": "Journal Title", "name": "journaltitle", "value": "Clinical Nutrition Open Science" }, { "label": "CrossRef DOI link to publisher maintained version", "name": "articlelink", "value": "https://doi.org/10.1016/j.nutos.2025.05.007" }, { "label": "Content Type", "name": "content_type", "value": "article" }, { "label": "Copyright", "name": "copyright", "value": "© 2025 Published by Elsevier Ltd on behalf of European Society for Clinical Nutrition and Metabolism." } ], "author": [ { "ORCID": "https://orcid.org/0000-0003-2764-6533", "affiliation": [], "authenticated-orcid": false, "family": "Wagner", "given": "Carol L.", "sequence": "first" }, { "affiliation": [], "family": "Baatz", "given": "John E.", "sequence": "additional" }, { "affiliation": [], "family": "Ebeling", "given": "Myla", "sequence": "additional" }, { "affiliation": [], "family": "Newton", "given": "Danforth A.", "sequence": "additional" }, { "affiliation": [], "family": "Shary", "given": "Judith R.", "sequence": "additional" }, { "affiliation": [], "family": "Gregoski", "given": "Mathew", "sequence": "additional" }, { "affiliation": [], "family": "Wagner", "given": "Mark T.", "sequence": "additional" }, { "affiliation": [], "family": "Zava", "given": "David", "sequence": "additional" }, { "affiliation": [], "family": "Baggerly", "given": "Carole", "sequence": "additional" }, { "affiliation": [], "family": "Ketchens", "given": "Sonya", "sequence": "additional" }, { "affiliation": [], "family": "Korte", "given": "Jeffrey", "sequence": "additional" }, { "affiliation": [], "family": "Hollis", "given": "Bruce W.", "sequence": "additional" } ], "container-title": "Clinical Nutrition Open Science", "container-title-short": "Clinical Nutrition Open Science", "content-domain": { "crossmark-restriction": true, "domain": [ "clinicalnutritionopenscience.com", "elsevier.com", "sciencedirect.com" ] }, "created": { "date-parts": [ [ 2025, 5, 27 ] ], "date-time": "2025-05-27T22:46:47Z", "timestamp": 1748386007000 }, "deposited": { "date-parts": [ [ 2025, 5, 27 ] ], "date-time": "2025-05-27T22:46:47Z", "timestamp": 1748386007000 }, "indexed": { "date-parts": [ [ 2025, 5, 28 ] ], "date-time": "2025-05-28T04:21:42Z", "timestamp": 1748406102150, "version": "3.41.0" }, "is-referenced-by-count": 0, "issued": { "date-parts": [ [ 2025, 5 ] ] }, "language": "en", "license": [ { "URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2025, 5, 1 ] ], "date-time": "2025-05-01T00:00:00Z", "timestamp": 1746057600000 } }, { "URL": "https://www.elsevier.com/legal/tdmrep-license", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2025, 5, 1 ] ], "date-time": "2025-05-01T00:00:00Z", "timestamp": 1746057600000 } }, { "URL": "http://creativecommons.org/licenses/by-nc-nd/4.0/", "content-version": "vor", "delay-in-days": 22, "start": { "date-parts": [ [ 2025, 5, 23 ] ], "date-time": "2025-05-23T00:00:00Z", "timestamp": 1747958400000 } } ], "link": [ { "URL": "https://api.elsevier.com/content/article/PII:S2667268525000567?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://api.elsevier.com/content/article/PII:S2667268525000567?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining" } ], "member": "78", "original-title": [], "prefix": "10.1016", "published": { "date-parts": [ [ 2025, 5 ] ] }, "published-print": { "date-parts": [ [ 2025, 5 ] ] }, "publisher": "Elsevier BV", "reference-count": 0, "references-count": 0, "relation": {}, "resource": { "primary": { "URL": "https://linkinghub.elsevier.com/retrieve/pii/S2667268525000567" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [], "subtitle": [], "title": "Exploring the association between vitamin D status and Corona Virus-19 infection in a cohort of adults aged 50 years and older", "type": "journal-article", "update-policy": "https://doi.org/10.1016/elsevier_cm_policy" }
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. IMA and WCH provide treatment protocols.
  or use drag and drop   
Submit